| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 07/22/2004 | US20040142953 Inhibitors of histone deacetylase |
| 07/22/2004 | US20040142948 Cardiovascular disorders; hypotensive agents ; respiratory system disorders; antiinflammatory agents; restenosis ; antiarthritic agents; atherosclerosis; anticholesterol agents; Alzheimer's disease; antidiabetic agents |
| 07/22/2004 | US20040142940 indole derivatives substituted by an amine at position 1, coupled to piperazine- or piperidine-type moieties anti-inflammatory agents |
| 07/22/2004 | US20040142933 treatment of schizophrenia and other central nervous system (CNS) disorders |
| 07/22/2004 | DE10300398A1 Verwendung von substituierten 2-Phenylbenzimidazolen als Arzneimittel Use of substituted 2-Phenylbenzimidazolen as drugs |
| 07/22/2004 | CA2512346A1 Imino acid derivatives for use as inhibitors of matrix metalloproteinases |
| 07/22/2004 | CA2512183A1 Pyrimidine-4,6-dicarboxylic acid diamides for use as selective mmp 13 inhibitors |
| 07/22/2004 | CA2511859A1 Novel cb 1 receptor inverse agonists |
| 07/22/2004 | CA2511646A1 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/21/2004 | EP1439590A2 Mono-, oligo- and poly-bis(thienyl) arylenes and their use as charge transport materials |
| 07/21/2004 | EP1439175A1 Pyrimidine compound and medicinal composition thereof |
| 07/21/2004 | EP1439174A1 4-imidazolin-2-one compounds |
| 07/21/2004 | EP1439173A2 Process for the production of linear organic oligomers |
| 07/21/2004 | EP1439169A1 DIFLUOROALKENE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE SAME, AND INTERMEDIATE THEREFOR |
| 07/21/2004 | EP1438973A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 07/21/2004 | EP1438349A1 Triarylamine containing monomers for optoelectronic devices |
| 07/21/2004 | EP1438307A2 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
| 07/21/2004 | EP1438298A1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 07/21/2004 | EP1438288A1 Substituted thioacetamides |
| 07/21/2004 | EP1438051A1 An enantiomerically pure diarylmethylpiperazine and methods of using same |
| 07/21/2004 | EP0975604B1 Pyridazinones as inhibitors of cyclooxygenase-2 |
| 07/21/2004 | CN1514833A Novel tyrosine kinase inhibitors |
| 07/21/2004 | CN1514829A Novel herbicides |
| 07/21/2004 | CN1514828A Pyrazole derivatives for treating HIV |
| 07/21/2004 | CN1514735A Ophthalmic composition comprising hyaluronic acid |
| 07/21/2004 | CN1158280C Substituted thiene-3-yl-sulfonyl amino (thio) carbonyl-triazolin (thi) ones |
| 07/21/2004 | CN1158279C 1-(P-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for production and utilization thereof and pharmaceutical preparations containing said compounds |
| 07/21/2004 | CN1158266C Compounds |
| 07/21/2004 | CN1158256C Pyrrolidine derivatives-CCR-3 receptor antagonists |
| 07/20/2004 | US6765011 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 07/20/2004 | US6765009 1,4-Disubstituted benzo-fused compounds |
| 07/20/2004 | US6765008 Pyrrolopyrimidines as CRF antagonists |
| 07/15/2004 | WO2004058753A1 Thiadiazoles or oxadiazoles and their use as inhibitors of jak protein kinase |
| 07/15/2004 | WO2004058752A1 Quinazoline compounds |
| 07/15/2004 | WO2004058748A1 Crystalline form of (3r,4r)-4-[3-(s)-hydroxy-3-(6-methoxyquinoline-4-yl)propyl]-1-[2-(2-thienylthio) ethyl]piperidine-3-carboxylic acid |
| 07/15/2004 | WO2004058747A1 Fc receptor modulating compounds and compositions |
| 07/15/2004 | WO2004058743A1 Novel substituted nitrogen-containing heterobicycles and use thereof as factor xa inhibitors |
| 07/15/2004 | WO2004058741A1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 07/15/2004 | WO2004058730A2 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 07/15/2004 | WO2004058729A1 New pyridazin-3(2h)-one derivatives |
| 07/15/2004 | WO2004058727A1 Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity |
| 07/15/2004 | WO2004058721A2 Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity |
| 07/15/2004 | WO2004058717A1 Isoquinolinone derivatives and their use as therapeutic agents |
| 07/15/2004 | WO2004058716A1 Substituted 4-aryl pyridines used as kiss-1 antagonists |
| 07/15/2004 | WO2004058702A2 4-[(4-(carboxyethyl) piperidinyl) methyl] pyrrolidines as modulators of chemokine receptor activity |
| 07/15/2004 | WO2004058302A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
| 07/15/2004 | WO2004058149A2 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles |
| 07/15/2004 | WO2004058143A2 High specificity anticancer pharmacological drug system, drug synthesis, and drug development process |
| 07/15/2004 | WO2004043366A3 Sulfonamides |
| 07/15/2004 | WO2004039318A3 Anti-infective biaryl compounds |
| 07/15/2004 | WO2004033632A3 Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace) |
| 07/15/2004 | WO2004032848A3 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 07/15/2004 | WO2004004714A1 Spirocyclic piperidines as mch1 antagonists and uses thereof |
| 07/15/2004 | WO2003086294A3 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 07/15/2004 | WO2003011853A8 6-aryl-4-aminopicolinates and their use as herbicides |
| 07/15/2004 | US20040138476 Polymer layers with coupling and solvents for dissolving layers and copper compounds |
| 07/15/2004 | US20040138461 Methods for the syntheses of alfentanil sufentanil and remifentanil |
| 07/15/2004 | US20040138286 Rho kinase inhibitors |
| 07/15/2004 | US20040138276 Metalloproteinase inhibitors |
| 07/15/2004 | US20040138267 Antitumor agents |
| 07/15/2004 | US20040138259 Pain management |
| 07/15/2004 | US20040138257 Chemical derivatives and their application as antitelomerase agent |
| 07/15/2004 | US20040138254 Central nervous system disorders; analgesics; headaches |
| 07/15/2004 | US20040138230 Psychological and central nervous system disorders; alzheimer's disease; Huntington's disease |
| 07/15/2004 | US20040138229 Platelet adenosine diphosphate receptor antagonists |
| 07/15/2004 | US20040138227 Antiserotonine agents; antidepressants |
| 07/15/2004 | US20040138225 Analgesics; gastrointestinal disorders; central nervous system injuries |
| 07/15/2004 | US20040138224 Pyrrolidine sulfonamides |
| 07/15/2004 | US20040138223 Novel amide derivatives and medicinal use thereof ugs |
| 07/15/2004 | US20040138220 Central nervous system disorder; gastrointestinal disorders; asthma; skin disorders; inflammatory bowel disorders; analgesics |
| 07/15/2004 | US20040138205 Viricides; hepatitis virus |
| 07/15/2004 | US20040135130 Nonlinear optical compounds and methods for their preparation |
| 07/15/2004 | DE10300017A1 Selektive MMP 13 Inhibitoren Selective MMP inhibitors 13 |
| 07/15/2004 | DE10300015A1 Iminosäurederivate als Inhibitoren von Matrix-Metallproteinasen Iminosäurederivate as inhibitors of matrix metalloproteinases |
| 07/15/2004 | CA2512099A1 New pyridazin-3(2h)-one derivatives |
| 07/15/2004 | CA2511356A1 Fc receptor modulating compounds and compositions |
| 07/15/2004 | CA2511349A1 New substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions |
| 07/15/2004 | CA2511199A1 Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 07/15/2004 | CA2509510A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
| 07/15/2004 | CA2508921A1 Quinazoline compounds |
| 07/15/2004 | CA2485429A1 Thiadiazoles or oxadiazoles and their use as inhibitors of jak protein kinase |
| 07/15/2004 | CA2485375A1 Spirocyclic piperidines as mch1 antagonists and uses thereof |
| 07/14/2004 | EP1437353A1 Alkyl ether derivatives or salts thereof |
| 07/14/2004 | EP1436287A2 Small organic molecule regulators of cell proliferation |
| 07/14/2004 | EP1436272A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 07/14/2004 | EP1436266A2 Methods and compositions of novel triazine compounds |
| 07/14/2004 | EP1436264A1 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 07/14/2004 | EP1436253A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 07/14/2004 | EP1436249A2 Muscarinic agonists |
| 07/14/2004 | EP1435944A1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 07/14/2004 | EP1435934A1 5'-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1235803B1 Urea compounds having muscarinic receptor antagonist activity |
| 07/14/2004 | EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 07/14/2004 | EP1214309B8 Preparing amidines derived from 6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid |
| 07/14/2004 | EP1204323B1 Fungicides |
| 07/14/2004 | EP1144368B1 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 07/14/2004 | CN1513175A Optical data carrier that contains merocyanine dye as light-absorbing compound in the information layer |
| 07/14/2004 | CN1512985A Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 07/14/2004 | CN1512982A Novel polyamine analogues as therapeutic and diagnostic agents |
| 07/14/2004 | CN1511832A Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives |